While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!

While China, India, and Korea are leading the pack in the Asian region for biologics, Taiwan has also been stepping up its efforts to boost its biologics sector. In 2009, the “Taiwan Biotechnology Takeoff Diamond Action Plan” was launched by the Taiwanese government, to strengthen the country’s translational research and commercialization skills, to establish a biotechnology venture capital fund, founding a Food and Drug Administration, and to create an integrated biotech incubation center.

Two biotechnology clusters have also already been built in Taiwan, with the Southern Taiwan Science Park hosting nearly 20 biopharmaceutical companies and the Hsinchu Biomedical Science Park expected to accommodate 30 biopharmaceutical manufacturers. The government also plans to create an integrated incubation center, to be developed in a third park called the National Biotechnology Development Park, which will also contain animal testing, R&D service, and legal information centers.

Biologics World Taiwan provides the FIRST and ONLY platform to access the senior decision-makers who will influence the future of Taiwan’s biologics industry. Taiwanese and international biopharma, biotechs, CMOs, CROs, and solution providers will convene to discuss strategic issues, leverage partnerships, share best practices, and capitalize on the potential of Taiwan’s growing biologics industry!